USA – BioMarin Pharmaceutical plans to submit clinical trial results to the Food and Drug Administration later this year, claiming that its gene therapy for hemophilia can prevent bleeding for…
Read MoreBiomarin plans to resubmit its experimental gene therapy to the FDA
